MAPTrix™ (Mussel Adhesive Protein based maTrix) : The First Leading Technology in Engineering Extracellular Matrix
Kollodis has developed a powerful and versatile platform technology; Mussel AdhesiveProtein based maTrix (MAPTrix™) platform. The MAPTrix™ platform technology recombinantly incorporates bioactive peptides, such as the RGD motif, into a mussel adhesive protein (MAP). The MAPTrix™ platform technology generates multi-functional biomaterials for life sciences and medical applications.
Features and Benefits
Our Kollodis’ MAPTrix™ platform technology generates new products for unmet needs in the biotech and related markets with the following features and benefits:
● Reproducible and reliable biofunctionality of recombinant mussel adhesive protein by stoichiometric incorporation of bioactive peptides
in to the mussel adhesive proteins
● Biofunctionalized mussel adhesive protein provides an“in vivo like” environment for life sciences applications (for example, in cell culture and
tissue engineering applications)
● Precise control of surface biofunctionality in the matrix or substrate of interest in terms of biofunctional peptide density or spatial
distribution
(patterned substrate)
● Convenient and reliable surface modification and/or coating of a substrate due to the inherent adhesive property of mussel adhesive protein
